Correction: Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function (Proceedings of the National Academy of Sciences (2015) 112 (3164-3169) DOI: 10.1073/pnas.1422373112);Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 10, 2015, Pages 3164-3169

  Lakhal Littleton, Samira ^a   Wolna, Magda ^a   Carr, Carolyn A ^a   Miller, Jack J J ^a   Christian, Helen C ^a   Ball, Vicky ^a   Santos, Ana ^b   Diaz, Rebeca ^b   Biggs, Daniel ^b   Stillion, Richard ^c   Holdship, Philip ^d   Larner, Fiona ^d   Tyler, Damian J ^a   Clarke, Kieran ^a   Davies, Benjamin ^b   Robbins, Peter A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cardiomyocyte; Ferroportin; Heart; Hepcidin; Iron

Indexed keywords

FERROPORTIN; HEPCIDIN; IRON; CATION TRANSPORT PROTEIN; METAL TRANSPORTING PROTEIN 1;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLS BY BODY ANATOMY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; HEART FUNCTION; HEART MUSCLE CELL; HOMEOSTASIS; IRON HOMEOSTASIS; IRON INTAKE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SURVIVAL; ANIMAL; C57BL MOUSE; HEART; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALIA; MAMMALIA; MUS;

ANIMALS; CATION TRANSPORT PROTEINS; HEART; HOMEOSTASIS; IRON; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84924299913     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1504383112     Document Type: Erratum

References (34)

1. Anker SD, et al.; FAIR-HF Trial Investigators (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361(25):2436-2448.
2. Okonko DO, et al. (2008) Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: A randomized, controlled, observer-blinded trial. J Am Coll Cardiol 51(2):103-112.
3. Klip IT, et al. (2013) Iron deficiency in chronic heart failure: An international pooled analysis. Am Heart J 165(4):575-582, e3.
4. Lekawanvijit S, Chattipakorn N (2009) Iron overload thalassemic cardiomyopathy: Iron status assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity. Can J Cardiol 25(4):213-218.
5. Murphy CJ, Oudit GY (2010) Iron-overload cardiomyopathy: Pathophysiology, diagnosis, and treatment. J Card Fail 16(11):888-900.
6. Allen KJ, et al. (2008) Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 358(3):221-230.
7. Walter PB, et al. (2006) Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 135(2):254-263.
8. Young IS, et al. (1994) Antioxidant status and lipid peroxidation in hereditary haemochromatosis. Free Radic Biol Med 16(3):393-397.
9. Ganz T (2005) Cellular iron: Ferroportin is the only way out. Cell Metab 1(3):155-157.
10. Donovan A, et al. (2005) The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 1(3):191-200.
11. Donovan A, et al. (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403(6771):776-81.
12. McGregor JA, et al. (2005) Impaired iron transport activity of ferroportin 1 in hereditary iron overload. J Membr Biol 206(1):3-7.
13. Nemeth E, et al. (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306(5704):2090-2093.
14. Qiao B, et al. (2012) Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab 15(6):918-924.
15. Ross SL, et al. (2012) Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. Cell Metab 15(6):905-917.
16. Abboud S, Haile DJ (2000) A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275(26):19906-19912.
17. Ge XH, et al. (2009) The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes. J Nutr Biochem 20(11):860-865.
18. Oudit GY, Trivieri MG, Khaper N, Liu PP, Backx PH (2006) Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy. J Mol Med (Berl) 84(5):349-364.
19. Kumfu S, Chattipakorn S, Chinda K, Fucharoen S, Chattipakorn N (2012) T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice. Eur J Haematol 88(6):535-548.
20. Liuzzi JP, Aydemir F, Nam H, Knutson MD, Cousins RJ (2006) Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci USA 103(37):13612-13617.
21. Worwood M (1990) Ferritin. Blood Rev 4(4):259-269.
22. Rouault TA (2006) The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2(8):406-414.
23. Rouault T, Klausner R (1997) Regulation of iron metabolism in eukaryotes. Curr Top Cell Regul 35(35):1-19.
24. McKie AT, et al. (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5(2):299-309.
25. Wolff NA, et al. (2011) Ferroportin 1 is expressed basolaterally in rat kidney proximal tubule cells and iron excess increases its membrane trafficking. J Cell Mol Med 15(2):209-219.
26. Moos T, Rosengren Nielsen T (2006) Ferroportin in the postnatal rat brain: Implications for axonal transport and neuronal export of iron. Semin Pediatr Neurol 13(3):149-157.
27. Babitt JL, Lin HY (2011) The molecular pathogenesis of hereditary hemochromatosis. Semin Liver Dis 31(3):280-292.
28. Pietrangelo A (2004) The ferroportin disease. Blood Cells Mol Dis 32(1):131-138.
29. Nicolas G, et al. (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98(15):8780-8785.
30. Lesbordes-Brion JC, et al. (2006) Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 108(4):1402-1405.
31. Meynard D, et al. (2009) Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 41(4):478-481.
32. Lallemand Y, Luria V, Haffner-Krausz R, Lonai P (1998) Maternally expressed PGK-Cre transgene as a tool for early and uniform activation of the Cre site-specific recombinase. Transgenic Res 7(2):105-112.
33. Agah R, et al. (1997) Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest 100(1):169-179.
34. Tyler DJ, et al. (2006) CINE-MR imaging of the normal and infarcted rat heart using an 11.7 T vertical bore MR system. J Cardiovasc Magn Reson 8(2):327-333.